Related Experiment Video
Updated: Jun 17, 2025

07:54
Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
18.6K
Genetic Heterogeneity in Cellular Angiofibromas
Ioannis Panagopoulos1, Kristin Andersen1, Ingvild Lobmaier2
1Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Genes, Chromosomes & Cancer
|August 9, 2024
Summary
Cellular angiofibromas show genetic diversity. Some tumors involve the RB1 gene, while others feature PLAG1 fusions, revealing distinct pathways in this rare neoplasm.
Area of Science:
- Oncology
- Genetics
- Pathology
Background:
- Cellular angiofibroma is a rare benign mesenchymal neoplasm.
- It shares similarities with spindle cell lipoma, often grouped in the 13q/RB1 family.
- Genetic analysis reveals underlying pathogenetic heterogeneity.
Purpose of the Study:
- To investigate the genetic basis of cellular angiofibroma.
- To identify distinct genetic pathways contributing to tumor development.
- To explore potential diagnostic implications of genetic findings.
Main Methods:
- Utilized G-banding/Karyotyping for chromosomal analysis.
- Employed array comparative genomic hybridization for copy number variations.
- Conducted RNA sequencing and direct sequencing for gene expression and mutations.
Main Results:
- One tumor exhibited del(13)(q12) with RB1 gene loss and reduced expression.
- Two tumors showed chromosome 8 abnormalities with PLAG1 gene fusions.
- Specific fusions identified: CTSB::PLAG1 and MIR99AHG::PLAG1, leading to elevated PLAG1 and IGF2 expression.
Conclusions:
- Identified two distinct genetic pathways in cellular angiofibromas.
- Pathway one involves the 13q/RB1 genetic alterations.
- Pathway two is characterized by PLAG1-chimeras, impacting gene expression.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Mechanism of Angiogenesis
5.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.4K

